Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The taq polymerase is not amplifying dna as intended. there is suspected contamination that is causing the taq to not work properly. kits which contain the affected lot of taq (taq polymerase vial lot # 864459) are not useable unless a different lot of taq is used.